H. Almirall et al., Ultradian and circadian body temperature and activity rhythms in chronic MPTP treated monkeys, NEUROP CLIN, 31(3), 2001, pp. 161-170
The body temperature and locomotor activity rhythms of seven 1-Methyl, 4-ph
enyl, 1,2,3,6-tetrahydropyridine (MPTP)-treated cynomolgous monkeys were re
gistered over a week on two separate occasions over an interval of 2 months
. Motor disability was absent in two animals and present in five: it was mi
ld in one, moderate in two and severe in two. Both temperature and motor ac
tivity were recorded every minute using a radio telemetry system. Analysis
of circadian rhythms revealed less robustness of the 24-hour circadian comp
onents of body temperature and locomotor activity with increasing motor imp
airment, and a fragmentation of the body temperature rhythm into 8 hour-per
iod components. Both total activity and daytime activity correlated inverse
ly with the degree of motor impairment, On the contrary, the monkeys did no
t show differences in night time activity. The proportions of variance acco
unted for by the body temperature and locomotor activity of 24 h + 12 h + 8
h components were correlated. Also, the average levels at which the circad
ian rhythm varies between body temperature and locomotor activity were corr
elated, The results were almost identical in the two 1-week recording sessi
ons.
The present study confirms individual differences in the vulnerability to M
PTP of the nigrostriatal system of monkeys, suggesting that if a cumulative
dose does not provoke stable motor alterations, this cumulative dose will
not produce circadian body temperature and locomotor activity rhythm altera
tions either. Similarly, if a dose is able to produce motor impairment, thi
s dose will also be able to produce circadian rhythm alterations. (C) 2001
Editions scientifiques et medicales Elsevier SAS.